Literature DB >> 24574546

A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibitory effect on Kir2.1.

Yosuke Kokunai1, Tomohiko Nakata, Mitsuru Furuta, Souhei Sakata, Hiromi Kimura, Takeshi Aiba, Masao Yoshinaga, Yusuke Osaki, Masayuki Nakamori, Hideki Itoh, Takako Sato, Tomoya Kubota, Kazushige Kadota, Katsuro Shindo, Hideki Mochizuki, Wataru Shimizu, Minoru Horie, Yasushi Okamura, Kinji Ohno, Masanori P Takahashi.   

Abstract

OBJECTIVE: To identify other causative genes for Andersen-Tawil syndrome, which is characterized by a triad of periodic paralysis, cardiac arrhythmia, and dysmorphic features. Andersen-Tawil syndrome is caused in a majority of cases by mutations in KCNJ2, which encodes the Kir2.1 subunit of the inwardly rectifying potassium channel.
METHODS: The proband exhibited episodic flaccid weakness and a characteristic TU-wave pattern, both suggestive of Andersen-Tawil syndrome, but did not harbor KCNJ2 mutations. We performed exome capture resequencing by restricting the analysis to genes that encode ion channels/associated proteins. The expression of gene products in heart and skeletal muscle tissues was examined by immunoblotting. The functional consequences of the mutation were investigated using a heterologous expression system in Xenopus oocytes, focusing on the interaction with the Kir2.1 subunit.
RESULTS: We identified a mutation in the KCNJ5 gene, which encodes the G-protein-activated inwardly rectifying potassium channel 4 (Kir3.4). Immunoblotting demonstrated significant expression of the Kir3.4 protein in human heart and skeletal muscles. The coexpression of Kir2.1 and mutant Kir3.4 in Xenopus oocytes reduced the inwardly rectifying current significantly compared with that observed in the presence of wild-type Kir3.4.
CONCLUSIONS: We propose that KCNJ5 is a second gene causing Andersen-Tawil syndrome. The inhibitory effects of mutant Kir3.4 on inwardly rectifying potassium channels may account for the clinical presentation in both skeletal and heart muscles.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24574546     DOI: 10.1212/WNL.0000000000000239

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  Coincidence of Andersen-Tawil syndrome and Marfan syndrome: A case report.

Authors:  Michalina Krych; Joanna Ponińska; Zofia T Bilińska; Rafał Płoski; Elżbieta K Biernacka
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-01-23       Impact factor: 1.468

2.  Andersen-Tawil syndrome: Clinical presentation and predictors of symptomatic arrhythmias - Possible role of polymorphisms K897T in KCNH2 and H558R in SCN5A gene.

Authors:  Michalina Krych; Elżbieta Katarzyna Biernacka; Joanna Ponińska; Piotr Kukla; Artur Filipecki; Robert Gajda; Can Hasdemir; Charles Antzelevitch; Agnieszka Kosiec; Małgorzata Szperl; Rafał Płoski; Maria Trusz-Gluza; Katarzyna Mizia-Stec; Piotr Hoffman
Journal:  J Cardiol       Date:  2017-03-21       Impact factor: 3.159

Review 3.  Catecholaminergic polymorphic ventricular tachycardia, an update.

Authors:  Andrés R Pérez-Riera; Raimundo Barbosa-Barros; Marianne P C de Rezende Barbosa; Rodrigo Daminello-Raimundo; Augusto A de Lucca; Luiz C de Abreu
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-10-19       Impact factor: 1.468

Review 4.  Channelopathies of skeletal muscle excitability.

Authors:  Stephen C Cannon
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

5.  SLC26A9 is selected for endoplasmic reticulum associated degradation (ERAD) via Hsp70-dependent targeting of the soluble STAS domain.

Authors:  Patrick G Needham; Jennifer L Goeckeler-Fried; Casey Zhang; Zhihao Sun; Adam R Wetzel; Carol A Bertrand; Jeffrey L Brodsky
Journal:  Biochem J       Date:  2021-12-22       Impact factor: 3.857

Review 6.  Inward rectifier potassium (Kir) channels in the retina: living our vision.

Authors:  Katie M Beverley; Bikash R Pattnaik
Journal:  Am J Physiol Cell Physiol       Date:  2022-08-01       Impact factor: 5.282

Review 7.  Hyperplasia in glands with hormone excess.

Authors:  Stephen J Marx
Journal:  Endocr Relat Cancer       Date:  2015-09-25       Impact factor: 5.678

Review 8.  Rare neurological channelopathies--networks to study patients, pathogenesis and treatment.

Authors:  Joanna C Jen; Tetsuo Ashizawa; Robert C Griggs; Michael F Waters
Journal:  Nat Rev Neurol       Date:  2016-03-04       Impact factor: 42.937

Review 9.  Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery.

Authors:  Paola Imbrici; Antonella Liantonio; Giulia M Camerino; Michela De Bellis; Claudia Camerino; Antonietta Mele; Arcangela Giustino; Sabata Pierno; Annamaria De Luca; Domenico Tricarico; Jean-Francois Desaphy; Diana Conte
Journal:  Front Pharmacol       Date:  2016-05-10       Impact factor: 5.810

Review 10.  Genetic neurological channelopathies: molecular genetics and clinical phenotypes.

Authors:  J Spillane; D M Kullmann; M G Hanna
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-11-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.